Viable germ cell tumor (GCT) identified at postchemotherapy retroperitoneal lymph node dissection (PC-RPLND): The significance of risk assignment and adjuvant chemotherapy

被引：1
|
作者：
Karanikolas, NT
Serio, A
Vickers, AJ
Carver, BS
Stephenson, AJ
Bosl, GJ
Joel, S
机构：
来源：
JOURNAL OF UROLOGY | 2006年 / 175卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)32836-2
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
590
引用
收藏
页码：191 / 191
页数：1
相关论文
共 50 条
  • [41] Clinical outcome of intermediate-and poor-risk patients with non-seminomatous germ cell testicular cancer (NSGCT) following post-chemotherapy retroperitoneal lymph node dissection (PC-RPLND)
    Shayegan, B
    Carver, BS
    Stephenson, AJ
    Bajorin, DF
    Motzer, RJ
    Bosl, GJ
    Sheinfeld, J
    JOURNAL OF UROLOGY, 2005, 173 (04): : 117 - 117
  • [42] Retroperitoneal surgery in the treatment of germ-cell tumors of the testis: retroperitoneal lymph node dissection (RPLND)
    Nicolai, N.
    Piva, A. Necchi L.
    Stagni, S.
    Catanzaro, M. A.
    Biasoni, D.
    Milani, A.
    Torelli, T.
    Salvioni, R.
    UROLOGIA JOURNAL, 2010, 77 (02) : 84 - 87
  • [43] Percentage of Teratoma in Orchiectomy and Risk of Retroperitoneal Teratoma at the Time of Postchemotherapy Retroperitoneal Lymph Node Dissection in Germ Cell Tumors
    Calaway, Adam C.
    Kern, Sean Q.
    Crook, David
    Tong, Yan
    Masterson, Timothy A.
    Adra, Nabil
    Einhorn, Lawrence H.
    Foster, Richard S.
    Cary, Clint
    JOURNAL OF UROLOGY, 2021, 206 (06): : 1430 - 1436
  • [44] Survival of good-risk germ cell tumor patients following postchemotherapy retroperitoneal lymph node dissection: The effect of bleomycin during induction chemotherapy
    Cary, K. Clint
    Pedrosa, Jose A.
    Kaimakliotis, Hristos Z.
    Masterson, Timothy A.
    Einhorn, Lawrence H.
    Foster, Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [45] Histology of good risk non-seminomatous germ cell tumor (NSGCT) patients following retroperitoneal lymph node dissection (PC-RPLND) after four cycles of etoposide and cisplatin (EPX4)
    Patel, MI
    Beck, S
    Bosl, GJ
    Motzer, R
    Bajorin, D
    Sheinfeld, J
    JOURNAL OF UROLOGY, 2003, 169 (04): : 176 - 177
  • [46] Post chemotherapy retroperitoneal lymph node dissection in germ cell tumor: robotic way
    Bora G.S.
    Panwar P.
    Mavuduru R.S.
    Devana S.K.
    Singh S.K.
    Mandal A.K.
    Journal of Robotic Surgery, 2017, 11 (2) : 279 - 285
  • [47] Orthotopic renal autotransplantation: A step forward during postchemotherapy retroperitoneal lymph node dissection for germ cell tumor
    Mor, Akash
    Gujela, Ajit
    Patel, Sachin
    Kumar, Vineet
    Prakash, Gagan
    INDIAN JOURNAL OF UROLOGY, 2024, 40 (04) : 273 - 275
  • [48] Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection
    Carver, Brett S.
    Shayegan, Bobby
    Eggener, Scott
    Stasi, Jason
    Motzer, Robert J.
    Bosl, George J.
    Sheinfeld, Joel
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (28) : 4365 - 4369
  • [49] Testicular Radiomics To Predict Pathology At Time of Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Tumor
    Venishetty, Nikit
    Taylor, Jacob
    Xi, Yin
    Howard, Jeffrey M.
    Ng, Yee Seng
    Wong, Daniel
    Woldu, Solomon L.
    De Leon, Alberto Diaz
    Pedrosa, Ivan
    Margulis, Vitaly
    Bagrodia, Aditya
    CLINICAL GENITOURINARY CANCER, 2024, 22 (01) : 33 - 37
  • [50] Association of lymph node count and survival after primary retroperitoneal lymph node dissection (RPLND) for testicular nonseminomatous germ cell tumor (NSGCT).
    Patel, Hiren, V
    Srivastava, Arnav
    Kim, Sinae
    Singer, Eric A.
    Kim, Isaac Yi
    Jang, Thomas L.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345